ArticleHealthcare (Basel, Switzerland)2024
Deciphering the Physical Characteristics of Ophthalmic Filters Used in Optometric Vision Therapy.
Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cone-Specific Filter-Based Neuromodulation: A Proposed Clinical Framework for Amblyopia, Strabismus, and ADHD.Clinics and practice · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis paper aimed to measure and characterize eleven monochromatic filters and twenty-two combinations used empirically to treat patients with visual dysfunctions to propose enhanced protocols based on solid evidence. Their wavelength, transmittance, and relative sensitivity were defined on the retinal cone cells.
methodsA double-beam UV-VIS-NIR spectrophotometer, VARIAN brand, Cary 5000 model, owned by the National Center of Metrology, with high precision and accuracy, was used to characterize all filters. Filters were purchased from Optomatters Corporation, Belgium.
resultsWhen two or three filters are combined, their transmittance and relative sensitivity on the retinal cone cells decrease regardless of wavelength. As a result, the efficiency of combined filters may decrease during treatments. Additionally, most filters and combinations, regardless of the wavelength, transmit a considerable percentage of light from the red spectrum. A depressant is the best monochromatic filter, and Upsilon-Neurasthenic is the strongest combination to stimulate blue cone cells. In contrast, Stimulant and Delta-Theta are best for red and green cone cells. Mu-Delta and Mu-Theta can be interchangeable, as well as Alpha-Delta and Alpha-Theta.
conclusionsResults suggest that the current phototherapy treatment protocol must be deeply revised, and the number of filters and combinations should be reduced to reduce costs and time and boost efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.